YIZHUANG BIOMEDICAL MERGERS AND ACQUISITION FUNDS
Yizhuang Biomedical Mergers and Acquisition Funds is an investment firm.
Similar Organizations
Beijing Baguan Touzi Guanli
Beijing Baguan Touzi Guanli is an investment firm.
Futian Guilding Fund
Futian Guilding Fund is an investment firm.
Xizang Zhiqian Touzi
Xizang Zhiqian Touzi is an investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-30 | Green Bamboo Bio | Yizhuang Biomedical Mergers and Acquisition Funds investment in Series C - Green Bamboo Bio | N/A |
| 2019-02-18 | GenomePrecision | Yizhuang Biomedical Mergers and Acquisition Funds investment in Series B - GenomePrecision | 100 M CNY |
| 2018-05-15 | Aitekang Medical | Yizhuang Biomedical Mergers and Acquisition Funds investment in Series B - Aitekang Medical | N/A |
More informations about "Yizhuang Biomedical Mergers and Acquisition Funds"
Yizhuang Biomedical Mergers and Acquisition Funds
Yizhuang Biomedical Mergers and Acquisition Funds is an investment firm. Search Crunchbase. ... Investments. People. Signals & News. Similar Companies. About. Yizhuang Biomedical โฆSee details»
Yizhuang Biomedical Mergers and Acquisition Funds
Yizhuang Biomedical Mergers and Acquisition Funds has made 3 investments. Their most recent investment was on Jun 30, 2022 , when Green Bamboo Bio raised How many investments has โฆSee details»
Yizhuang Biomedical Mergers and Acquisition Funds
Yizhuang Biomedical Mergers and Acquisition Funds is an investment firm.See details»
Beijing GenomePrecision Raises $15 Million for Molecular โฆ
Feb 19, 2019 GenomePrecision Technology of Beijing completed a $15 million B round, led by Yizhuang Biomedical M&A Fund. A six-year-old company, GenomePrecision develops โฆSee details»
Yizhuang Biomedical Mergers and Acquisition Funds
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2019. The standard case for the fund is to invest in rounds with 3-4 partakers. Despite โฆSee details»
Insight Capital โ 17 Portfolio companies, 22 ... - Unicorn Nest
The meaningful sponsors for the fund in investment in the same round are Yizhuang Biomedical Mergers and Acquisition Funds, THG Ventures, Qiming Venture Partners. In the next rounds โฆSee details»
Yizhuang Biomedical Mergers and Acquisition Funds - CB Insights
Yizhuang Biomedical Mergers and Acquisition Funds (ไบฆๅบ็็ฉๅป่ฏๅนถ่ดญๅบ้) is based in China. Use the CB Insights Platform to explore Yizhuang Biomedical Mergers and Acquisition โฆSee details»
KYinno Company Profile 2024: Valuation, Funding & Investors
Corporate Office. Room 602 No.3 Building, Yizhuang Biomedical Park; No. 88, Kechuang Six Street, Yizhuang Economic and Technological Development East ZoneSee details»
[IPO] Immune Ark completed seed round financing of tens of โฆ
Sywin Capital was jointly initiated and established by Sysun Pharmaceutical (SZ:300485), Yizhuang International Investment Co., LTD and Yizhuang Biomedical Park in 2016. โฆSee details»
Aitekang Medical - Products, Competitors, Financials, Employees ...
Investors of Aitekang Medical include Insight Capital and Yizhuang Biomedical Mergers and Acquisition Funds. Loading... 498 Seventh Avenue 12th floor New York, NY 10018See details»
Green Bamboo Bio - Crunchbase Company Profile & Funding
Green Bamboo Bio raised an undisclosed amount / Series C from CNCB Capital and Yizhuang Biomedical Mergers and Acquisition Funds. Discover more funding rounds ... 1,365 Number of โฆSee details»
The top 10 biopharma M&A deals of 2023 - Fierce Pharma
While the biopharma industry's dealmaking totals have yet to eclipse the heady highs of 2019, mergers and acquisitions were back on the menu in a big way in 2023. Last year, the value of โฆSee details»
Life sciences M&A, divestments and restructuring - Deloitte
Oct 24, 2024 Over the past five years, M&A activity has rebounded strongly, driven in part by a step-up in investor activism. M&A has become a critical element in the corporate strategy of โฆSee details»
Aitekang Medical Stock Price, Funding, Valuation, Revenue
See Aitekang Medical funding rounds, investors, investments, exits and more. Evaluate their financials based on Aitekang Medical's post-money valuation and revenue.See details»
Biotech M&A has plateaued. Track the deals that are happening โฆ
Nov 26, 2024 Many of today's most lucrative medicines, from the life-saving cancer treatment Keytruda to the anti-inflammatory agent Enbrel, might not have become so without mergers โฆSee details»
Sigma Square Capital โ 14 Deals, 12 Portfolio startups, Statistics ...
Yizhuang Biomedical Mergers and Acquisition Funds. Sigma Square Capital. Juren Capital. ... โ ABclonal is also currently in talks to acquire a contract research organization focused on single โฆSee details»
Healthcare mergers: Expecting more in 2024 - OncLive
Aug 18, 2023 And KPMG is projecting that healthcare mergers and acquisition activity may be a bit more subdued for the remainder of the year. In the first half of 2023, there were 245 โฆSee details»
Dynamic Balance Capital โ 34 Portfolio companies, 37
The meaningful sponsors for the fund in investment in the same round are Yizhuang Biomedical Mergers and Acquisition Funds, Three Gorges Xintai Fund, Sigma Square Capital. In the next โฆSee details»
Yizun Medicine Company Profile 2024: Valuation, Funding
Yizun Medicine General Information Description. Developer of cell therapy designed for solid tumors. The company focuses on research and development on solid tumor treatment and โฆSee details»
The latest in Canadian health clinic acquisitions
Dec 13, 2021 The ongoing surge in merger and acquisition transactions since 2020 has been widely commented on throughout the past year. As the initial hesitancy towards engaging in โฆSee details»